Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The study was an open label, balanced, randomized, two-treatment, four-period, two sequence,
single oral dose, crossover, fully replicate bioequivalence study of two formulations of
Valsartan 320 mg under fasting conditions.